Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
editorial
. 1991 Mar;63(3):337–342. doi: 10.1038/bjc.1991.80

Cancer cachexia.

M J Tisdale
PMCID: PMC1971880  PMID: 2003972

Full text

PDF
340

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisner J., Tchekmedyian N. S., Tait N., Parnes H., Novak M. Studies of high-dose megestrol acetate: potential applications in cachexia. Semin Oncol. 1988 Apr;15(2 Suppl 1):68–75. [PubMed] [Google Scholar]
  2. Balkwill F., Osborne R., Burke F., Naylor S., Talbot D., Durbin H., Tavernier J., Fiers W. Evidence for tumour necrosis factor/cachectin production in cancer. Lancet. 1987 Nov 28;2(8570):1229–1232. doi: 10.1016/s0140-6736(87)91850-2. [DOI] [PubMed] [Google Scholar]
  3. Barnes D., Sato G. Methods for growth of cultured cells in serum-free medium. Anal Biochem. 1980 Mar 1;102(2):255–270. doi: 10.1016/0003-2697(80)90151-7. [DOI] [PubMed] [Google Scholar]
  4. Beck S. A., Tisdale M. J. Effect of insulin on weight loss and tumour growth in a cachexia model. Br J Cancer. 1989 May;59(5):677–681. doi: 10.1038/bjc.1989.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beck S. A., Tisdale M. J. Effect of megestrol acetate on weight loss induced by tumour necrosis factor alpha and a cachexia-inducing tumour (MAC16) in NMRI mice. Br J Cancer. 1990 Sep;62(3):420–424. doi: 10.1038/bjc.1990.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Beck S. A., Tisdale M. J. Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice. Cancer Res. 1989 Jul 15;49(14):3800–3804. [PubMed] [Google Scholar]
  7. Beck S. A., Tisdale M. J. Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host. Cancer Res. 1987 Nov 15;47(22):5919–5923. [PubMed] [Google Scholar]
  8. Beutler B., Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med. 1987 Feb 12;316(7):379–385. doi: 10.1056/NEJM198702123160705. [DOI] [PubMed] [Google Scholar]
  9. Beutler B., Greenwald D., Hulmes J. D., Chang M., Pan Y. C., Mathison J., Ulevitch R., Cerami A. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature. 1985 Aug 8;316(6028):552–554. doi: 10.1038/316552a0. [DOI] [PubMed] [Google Scholar]
  10. Bibby M. C., Double J. A., Ali S. A., Fearon K. C., Brennan R. A., Tisdale M. J. Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals. J Natl Cancer Inst. 1987 Mar;78(3):539–546. [PubMed] [Google Scholar]
  11. Chlebowski R. T. Critical evaluation of the role of nutritional support with chemotherapy. Cancer. 1985 Jan 1;55(1 Suppl):268–272. doi: 10.1002/1097-0142(19850101)55:1+<268::aid-cncr2820551311>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  12. Costa G. Cachexia, the metabolic component of neoplastic diseases. Cancer Res. 1977 Jul;37(7 Pt 2):2327–2335. [PubMed] [Google Scholar]
  13. Cotter R., Taylor C. A., Johnson R., Rowe W. B. A metabolic comparison of a pure long-chain triglyceride lipid emulsion (LCT) and various medium-chain triglyceride (MCT)-LCT combination emulsions in dogs. Am J Clin Nutr. 1987 May;45(5):927–939. doi: 10.1093/ajcn/45.5.927. [DOI] [PubMed] [Google Scholar]
  14. Demetrakopoulos G. E., Brennan M. F. Tumoricidal potential of nutritional manipulations. Cancer Res. 1982;42(2 Suppl):756s–765s. [PubMed] [Google Scholar]
  15. Fearon K. C., Borland W., Preston T., Tisdale M. J., Shenkin A., Calman K. C. Cancer cachexia: influence of systemic ketosis on substrate levels and nitrogen metabolism. Am J Clin Nutr. 1988 Jan;47(1):42–48. doi: 10.1093/ajcn/47.1.42. [DOI] [PubMed] [Google Scholar]
  16. Garattini S., Bizzi A., Donelli M. G., Guaitani A., Samanin R., Spreafico F. Anorexia and cancer in animals and man. Cancer Treat Rev. 1980 Sep;7(3):115–139. doi: 10.1016/s0305-7372(80)80027-2. [DOI] [PubMed] [Google Scholar]
  17. Gold J. Cancer cachexia and gluconeogenesis. Ann N Y Acad Sci. 1974;230:103–110. doi: 10.1111/j.1749-6632.1974.tb14440.x. [DOI] [PubMed] [Google Scholar]
  18. Groundwater P., Beck S. A., Barton C., Adamson C., Ferrier I. N., Tisdale M. J. Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients. Br J Cancer. 1990 Nov;62(5):816–821. doi: 10.1038/bjc.1990.384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Grunfeld C., Wilking H., Neese R., Gavin L. A., Moser A. H., Gulli R., Serio M. K., Feingold K. R. Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats. Cancer Res. 1989 May 15;49(10):2554–2560. [PubMed] [Google Scholar]
  20. Holland J. F., Ohnuma T. Lessons from the study of induced alterations in amino acids in patients with cancer. Cancer Treat Rep. 1979 Jun;63(6):1013–1018. [PubMed] [Google Scholar]
  21. Hollander D. M., Ebert E. C., Roberts A. I., Devereux D. F. Effects of tumor type and burden on carcass lipid depletion in mice. Surgery. 1986 Aug;100(2):292–297. [PubMed] [Google Scholar]
  22. Imagawa W., Bandyopadhyay G. K., Wallace D., Nandi S. Phospholipids containing polyunsaturated fatty acyl groups are mitogenic for normal mouse mammary epithelial cells in serum-free primary cell culture. Proc Natl Acad Sci U S A. 1989 Jun;86(11):4122–4126. doi: 10.1073/pnas.86.11.4122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Karmali R. A., Chao C. C., Basu A., Modak M. II. Effect of n-3 and n-6 fatty acids on mammary H-ras expression and PGE2 levels in DMBA-treated rats. Anticancer Res. 1989 Jul-Aug;9(4):1169–1174. [PubMed] [Google Scholar]
  24. Kitada S., Hays E. F., Mead J. F. A lipid mobilizing factor in serum of tumor-bearing mice. Lipids. 1980 Mar;15(3):168–174. doi: 10.1007/BF02540964. [DOI] [PubMed] [Google Scholar]
  25. Kitada S., Hays E. F., Mead J. F. Characterization of a lipid mobilizing factor from tumors. Prog Lipid Res. 1981;20:823–826. doi: 10.1016/0163-7827(81)90155-7. [DOI] [PubMed] [Google Scholar]
  26. Kitada S., Hays E. F., Mead J. F., Zabin I. Lipolysis induction in adipocytes by a protein from tumor cells. J Cell Biochem. 1982;20(4):409–416. doi: 10.1002/jcb.240200410. [DOI] [PubMed] [Google Scholar]
  27. Lazo P. A. Tumour induction of host leucine starvation. FEBS Lett. 1981 Dec 7;135(2):229–231. doi: 10.1016/0014-5793(81)80788-0. [DOI] [PubMed] [Google Scholar]
  28. Lähdevirta J., Maury C. P., Teppo A. M., Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med. 1988 Sep;85(3):289–291. doi: 10.1016/0002-9343(88)90576-1. [DOI] [PubMed] [Google Scholar]
  29. Mahony S. M., Beck S. A., Tisdale M. J. Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour. Br J Cancer. 1988 Apr;57(4):385–389. doi: 10.1038/bjc.1988.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mahony S. M., Tisdale M. J. Induction of weight loss and metabolic alterations by human recombinant tumour necrosis factor. Br J Cancer. 1988 Sep;58(3):345–349. doi: 10.1038/bjc.1988.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Masuno H., Yamasaki N., Okuda H. Purification and characterization of a lipolytic factor (toxohormone-L) from cell-free fluid of ascites sarcoma 180. Cancer Res. 1981 Jan;41(1):284–288. [PubMed] [Google Scholar]
  32. Moley J. F., Morrison S. D., Gorschboth C. M., Norton J. A. Body composition changes in rats with experimental cancer cachexia: improvement with exogenous insulin. Cancer Res. 1988 May 15;48(10):2784–2787. [PubMed] [Google Scholar]
  33. Mullen B. J., Harris R. B., Patton J. S., Martin R. J. Recombinant tumor necrosis factor-alpha chronically administered in rats: lack of cachectic effect. Proc Soc Exp Biol Med. 1990 Apr;193(4):318–325. doi: 10.3181/00379727-193-43042. [DOI] [PubMed] [Google Scholar]
  34. Nathanson L., Hall T. C. A spectrum of tumors that produce paraneoplastic syndromes. Lung tumors: how they produce their syndromes. Ann N Y Acad Sci. 1974;230:367–377. doi: 10.1111/j.1749-6632.1974.tb14471.x. [DOI] [PubMed] [Google Scholar]
  35. Norton J. A., Moley J. F., Green M. V., Carson R. E., Morrison S. D. Parabiotic transfer of cancer anorexia/cachexia in male rats. Cancer Res. 1985 Nov;45(11 Pt 1):5547–5552. [PubMed] [Google Scholar]
  36. Oliff A., Defeo-Jones D., Boyer M., Martinez D., Kiefer D., Vuocolo G., Wolfe A., Socher S. H. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell. 1987 Aug 14;50(4):555–563. doi: 10.1016/0092-8674(87)90028-6. [DOI] [PubMed] [Google Scholar]
  37. Pizer L. I., Regan J. D. Basis for the serine requirement in leukemic and normal human leukocytes. Reduced levels of the enzymes in the phosphorylated pathway. J Natl Cancer Inst. 1972 Jun;48(6):1897–1900. [PubMed] [Google Scholar]
  38. Rouzer C. A., Cerami A. Hypertriglyceridemia associated with Trypanosoma brucei brucei infection in rabbits: role of defective triglyceride removal. Mol Biochem Parasitol. 1980 Oct;2(1):31–38. doi: 10.1016/0166-6851(80)90046-8. [DOI] [PubMed] [Google Scholar]
  39. Saarinen U. M., Koskelo E. K., Teppo A. M., Siimes M. A. Tumor necrosis factor in children with malignancies. Cancer Res. 1990 Feb 1;50(3):592–595. [PubMed] [Google Scholar]
  40. Sauer L. A., Dauchy R. T. Blood nutrient concentrations and tumor growth in vivo in rats: relationships during the onset of an acute fast. Cancer Res. 1987 Feb 15;47(4):1065–1068. [PubMed] [Google Scholar]
  41. Sauer L. A., Dauchy R. T. Stimulation of tumor growth in adult rats in vivo during acute streptozotocin-induced diabetes. Cancer Res. 1987 Apr 1;47(7):1756–1761. [PubMed] [Google Scholar]
  42. Schein P. S., Kisner D., Haller D., Blecher M., Hamosh M. Cachexia of malignancy: potential role of insulin in nutritional management. Cancer. 1979 May;43(5 Suppl):2070–2076. doi: 10.1002/1097-0142(197905)43:5+<2070::aid-cncr2820430715>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  43. Selby P., Hobbs S., Viner C., Jackson E., Jones A., Newell D., Calvert A. H., McElwain T., Fearon K., Humphreys J. Tumour necrosis factor in man: clinical and biological observations. Br J Cancer. 1987 Dec;56(6):803–808. doi: 10.1038/bjc.1987.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sharp G. W., Hynie S. Stimulation of intestinal adenyl cyclase by cholera toxin. Nature. 1971 Jan 22;229(5282):266–269. doi: 10.1038/229266a0. [DOI] [PubMed] [Google Scholar]
  45. Sherry B. A., Gelin J., Fong Y., Marano M., Wei H., Cerami A., Lowry S. F., Lundholm K. G., Moldawer L. L. Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. FASEB J. 1989 Jun;3(8):1956–1962. doi: 10.1096/fasebj.3.8.2721856. [DOI] [PubMed] [Google Scholar]
  46. Socher S. H., Martinez D., Craig J. B., Kuhn J. G., Oliff A. Tumor necrosis factor not detectable in patients with clinical cancer cachexia. J Natl Cancer Inst. 1988 Jun 15;80(8):595–598. doi: 10.1093/jnci/80.8.595. [DOI] [PubMed] [Google Scholar]
  47. Stein T. P. Cachexia, gluconeogenesis and progressive weight loss in cancer patients. J Theor Biol. 1978 Jul 6;73(1):51–59. doi: 10.1016/0022-5193(78)90179-0. [DOI] [PubMed] [Google Scholar]
  48. Strain A. J., Easty G. C., Neville A. M. An experimental model of cachexia induced by a xenografted human tumor. J Natl Cancer Inst. 1980 Feb;64(2):217–221. doi: 10.1093/jnci/64.2.217. [DOI] [PubMed] [Google Scholar]
  49. Tanaka Y., Eda H., Tanaka T., Udagawa T., Ishikawa T., Horii I., Ishitsuka H., Kataoka T., Taguchi T. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res. 1990 Apr 15;50(8):2290–2295. [PubMed] [Google Scholar]
  50. Tisdale M. J., Beck S. A. Inhibition of tumour-induced lipolysis in vitro and cachexia and tumour growth in vivo by eicosapentaenoic acid. Biochem Pharmacol. 1991 Jan 1;41(1):103–107. doi: 10.1016/0006-2952(91)90016-x. [DOI] [PubMed] [Google Scholar]
  51. Tisdale M. J., Brennan R. A., Fearon K. C. Reduction of weight loss and tumour size in a cachexia model by a high fat diet. Br J Cancer. 1987 Jul;56(1):39–43. doi: 10.1038/bjc.1987.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Tisdale M. J., Dhesi J. K. Inhibition of weight loss by omega-3 fatty acids in an experimental cachexia model. Cancer Res. 1990 Aug 15;50(16):5022–5026. [PubMed] [Google Scholar]
  53. Tisdale M. J. Effect of methionine replacement by homocysteine on the growth of cells. Cell Biol Int Rep. 1980 Jun;4(6):563–570. doi: 10.1016/0309-1651(80)90022-3. [DOI] [PubMed] [Google Scholar]
  54. Tracey K. J., Wei H., Manogue K. R., Fong Y., Hesse D. G., Nguyen H. T., Kuo G. C., Beutler B., Cotran R. S., Cerami A. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med. 1988 Mar 1;167(3):1211–1227. doi: 10.1084/jem.167.3.1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Tsai M. H., Yu C. L., Wei F. S., Stacey D. W. The effect of GTPase activating protein upon ras is inhibited by mitogenically responsive lipids. Science. 1989 Jan 27;243(4890):522–526. doi: 10.1126/science.2536192. [DOI] [PubMed] [Google Scholar]
  56. Uren J. R., Lazarus H. L-cyst(e)ine requirements of malignant cells and progress toward depletion therapy. Cancer Treat Rep. 1979 Jun;63(6):1073–1079. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES